Nexentis Technologies Inc. Common Stock (NXTS)

About NXTS

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all m…

Sector

Industrials

Industry

Agricultural Chemicals

Employees

7

Website

www.n2off.com/

Fundamentals

1-day range

$1.76$2.05

Market cap

$2.80M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-55.61

Dividend yield

—

Beta

1.87

Avg. volume

1.32M

Nexentis Technologies Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• NXTS

  Nexentis Technologies Inc. Common Stock

  $1.77

  ▼ 7.33%
  Market cap $2.80MP/E —
  $1.43$58.8
• BIOX

  Bioceres Crop Solutions Corp. Ordinary Shares

  $0.4199

  ▲ 3.94%
  Market cap $22.76MP/E —
  $0.301$3.07
• AVD

  American Vanguard Corporation Common Stock ($0.10 Par Value)

  $2.2

  ▲ 0.92%
  Market cap $88.01MP/E —
  $2.05$5.92
• CBUS

  Cibus Inc. Class A Common Stock

  $1.66

  ▼ 0.90%
  Market cap $142.74MP/E —
  $1.09$4.19
• SMG

  Scotts Miracle-Gro Company (The) Common Stock

  $60.56

  ▼ 0.05%
  Market cap $3.61BP/E 49.61
  $52$75.34
• MOS

  Mosaic Company (The) Common Stock

  $23.61

  ▼ 0.63%
  Market cap $7.46BP/E —
  $19.8$36.99
• CF

  CF Industries Holdings Inc. Common Stock

  $125.76

  ▲ 0.04%
  Market cap $17.93BP/E 8.64
  $75.42$141.96

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held

58

Total value held

$38

Institutional holders

1